氯吡格雷抵抗的发生率及其影响因素

被引:7
作者
郭丽敏
崔炜
机构
[1] 河北医科大学第二医院心内科
[2] 河北医科大学第二医院心内科 河北石家庄
[3] 河北石家庄
关键词
氯吡格雷; 氯吡格雷抵抗;
D O I
暂无
中图分类号
R972.6 [];
学科分类号
1007 ;
摘要
氯吡格雷广泛应用于急性冠脉综合征及行经皮冠状动脉介入治疗的患者,但个体之间对氯吡格雷的反应各不相同,部分病人对氯吡格雷反应较差甚至无反应。就氯吡格雷抵抗的发生率、影响因素作一综述。
引用
收藏
页码:120 / 123
页数:4
相关论文
共 24 条
[1]  
The metabolism of clopidogrel is catalyzed by human cytochrome P450 3 A and is inhibited by atorvastatin. Clarke TA,Waskell LA. Drug Metabolism and Disposition . 2003
[2]  
Individual variations of platelet inhibition after loading doses of clopidogrel. Jaremo P,Lindahl TL,Fransson SG,et al. Journal of Internal Medicine . 2002
[3]  
Durability of platelet inhibition by clopidogrel. Bliden KP,Gurbel PA. The American Journal of Cardiology . 2003
[4]  
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions. Lepantalo A,Virtanen KS,Heikkila J,et al. European Heart Journal . 2004
[5]  
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Cutlip DF,Baim DS,Ho KK,et al. Circulation . 2001
[6]  
Reduced inhibition by abciximab in platelets with the PI A2 polymorphism. Wheeler GL,Braden GA,Bray PF,et al. American Heart Journal . 2002
[7]  
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Lau WC,Waskell LA,Watkins PB,et al. Circulation . 2003
[8]  
Lineage-specific overexpression of the P2 Y1 receptor induces platelet hyper-reactivity in transgenic mice. Hechler B,Zhang Y,Eckly A,et al. Journal of Thrombosis and Haemostasis . 2003
[9]  
The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine. Lale A,Herbert JM,Savi P. Thrombosis and Haemostasis . 2003
[10]  
Effect of a high dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Muller I,Seyfarth M,Rudiger S,et al. Heart . 2001